Mr. Market is currently offering Align Technology, Inc. at $171.53.
The business passes only 2 of 7 of Graham's defensive criteria — well below his required standard.
At $171.53, the stock trades at a 102% premium to its Graham Number of $84.78. Graham would consider this price speculative.
There is no margin of safety at the current price. Graham would advise patience and waiting for a better entry point.
Trading at 28.4x NCAV. Expected for most quality businesses — NCAV was designed to find depression-era bargains and rarely applies to modern profitable companies..
Conclusion: By Graham's standards, this stock is speculative at its current price. The intelligent investor would look elsewhere or wait.
Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products, Invisalign training, adjusting tools used by dental professionals during treatment, ancillary Invisalign accessory products, and other oral health products; Invisalign Professional Whitening system; Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; exocad, a computer-aided design and computer-aided manufacturing software; orthodontist software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers; and restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons. This segment also offers Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface for dental consultations; iTero TimeLapse technology for doctors or practitioners to compare a patient's historic 3D scans to the present-day scan; and subscription software, disposables, rents scanners, and pay per scan services. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Gross Profit % | 67.2% ▼ | 70.0% | 70.1% | 70.5% | N/A |
| Operating Margin % | 14.5% ▼ | 16.8% | 17.0% | 17.5% | N/A |
| Net Income % | 10.2% ▼ | 10.5% | 11.5% | 9.7% | N/A |
| Diluted EPS | 5.65 ▲ | 5.62 | 5.81 | 4.61 | N/A |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | $6.2B | $6.2B | $6.1B | $5.9B | N/A |
| Total Debt | $114M ↓ | $119M | $127M | $127M | N/A |
| Working Capital | $697M ▲ | $454M | $380M | $499M | N/A |
| Years to Pay Debt | 0.28 | 0.28 | 0.28 | 0.35 | N/A |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | $491M ▼ | $623M | $608M | $277M | N/A |
| Owner Earnings | $750M | $682M | $765M | $779M | N/A |
| CapEx % of Net Income | 25.0% | 27.4% | 39.9% | 80.7% | N/A |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Capital Expenditure % of Net Income | 25.0% | 27.4% | 39.9% | 80.7% | N/A |
| Repurchase of Capital Stock | -$466M | -$353M | -$592M | -$435M | N/A |
| Free Cash Flow | $491M ▼ | $623M ▲ | $608M ▲ | $277M • | N/A • |
| Warren's Owner Earnings | $750M | $682M | $765M | $779M | N/A |
| Institution | % Owned | Shares |
|---|---|---|
| Vanguard Group Inc | 11.42% | 8,179,779 |
| Capital International Investors | 6.48% | 4,643,221 |
| Blackrock Inc. | 6.09% | 4,360,560 |
| State Street Corporation | 3.53% | 2,528,258 |
| Ninety One UK Ltd | 3.11% | 2,228,214 |
| FMR, LLC | 2.79% | 1,999,531 |
| T. Rowe Price Investment Management, Inc. | 2.56% | 1,830,038 |
| Geode Capital Management, LLC | 2.46% | 1,759,887 |
Align Technology, Inc. (ALGN) fundamental analysis — Overall grade B based on profitability, financial health, valuation and cash flow. Graham's Fair Value: $84.78. Margin of safety: 0%. Gross profit margin: 67.2%. Operating margin: 14.5%. Net margin: 10.2%. Market cap: $12.3B. Sector: Healthcare. Industry: Medical Instruments & Supplies. Analysis powered by 360investing — free fundamental stock analysis based on Benjamin Graham and Warren Buffett principles.
Disclaimer: 360investing is provided for informational and educational purposes only and does not constitute financial, investment, legal, or tax advice. All data is sourced from public third-party providers and may be delayed, inaccurate, or incomplete. Past performance is not indicative of future results. Analysis, scores, and valuations are algorithmic and do not represent professional investment recommendations. Always conduct your own due diligence and consult a qualified financial adviser before making any investment decision. Use of this tool constitutes acceptance that 360investing and its operators bear no liability for decisions made based on information presented here.